The Munich Myocardial Infarction Registry: Impact of C-reactive protein and kidney function on hospital mortality in diabetic patients

Diabetes and Vascular Disease Research

Volumn 7, Issue 3, 2010, Pages 225-230

  Schnell, Oliver ^a   Braun, Karl Friedrich ^b   Müller, Martin ^b   Standl, Eberhard ^b   Otter, Wolfgang ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Diabetes Research Institute   (Germany)

^c Center of Internal Medicine   (Germany)

Author keywords

C reactive protein; Coronary artery disease; Creatinine; Diabetes; Heart; Impaired kidney function; Mortality; Myocardial infarction; Prognosis

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN BLOOD LEVEL; REGISTER; RISK FACTOR;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; GERMANY; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; KIDNEY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT ADMISSION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 79551706683     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.1177/1479164110372641     Document Type: Article

References (35)

1. Al Suwaidi J., Reddan DN, Williams K., et al. (2002) Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106 (8). 974-80. (Pubitemid 34925333)
2. Anavekar NS, McMurray JJ, Velazquez EJ, et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (13). 1285-95. (Pubitemid 39258422)
3. Wright RS, Reeder GS, Herzog CA, et al. (2002) Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 137 (7). 563-70.
4. Standl E. and Schnell O. (2000) A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia 43 (12). 1455-69. (Pubitemid 32734852)
5. Lowel H., Koenig W., Engel S., Hormann A. and Keil U. (2000) The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 43 (2). 218-26. (Pubitemid 30126827)
6. Granger CB, Califf RM, Young S., et al. (1993) Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 21 (4). 920-5. (Pubitemid 23106156)
7. Yudkin JS and Oswald GA (1988) Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 11 (4). 351-8.
8. Haffner SM, Lehto S., Ronnemaa T., Pyorala K. and Laakso M. (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (4). 229-34. (Pubitemid 28350165)
9. Libby P., Ridker PM and Maseri A. (2002) Inflammation and atherosclerosis. Circulation 105 (9). 1135-43. (Pubitemid 34212626)
10. Otter W., Standl E. and Schnell O. (2004) [Inflammation and atherogenesis in diabetes mellitus-new therapeutic approaches]. Herz 29 (5). 524-31. (Pubitemid 39166110)
11. Ridker PM, Cushman M., Stampfer MJ, Tracy RP and Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (14). 973-9. (Pubitemid 27152782)
12. Ross R. (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340 (2). 115-26.
13. Blake GJ and Ridker PM (2003) C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41 (4 Suppl S). 42.
14. Pai JK, Pischon T., Ma J., et al. (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351 (25). 2599-610. (Pubitemid 39628581)
15. Rowe IF, Walker LN, Bowyer DE, Soutar AK, Smith LC and Pepys MB (1985) Immunohistochemical studies of C-reactive protein and apolipoprotein B in inflammatory and arterial lesions. J Pathol 145 (3). 241-9. (Pubitemid 15053318)
16. Blake GJ and Ridker PM (2002) Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252 (4). 283-94. (Pubitemid 35253696)
17. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy RP and Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (1). 42-7. (Pubitemid 30430551)
18. Festa A., Hanley AJG, Tracy RP, D'Agostino R. and Haffner SM (2003) Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 108 (15). 1822-30. (Pubitemid 37296091)
19. Otter W., Kleybrink S., Doering W., Standl E. and Schnell O. (2004) Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med 21 (2). 183-7. (Pubitemid 38221819)
20. Freeman RV, Mehta RH, Al Badr W., Cooper JV, Kline-Rogers E. and Eagle KA (2003) Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/ IIIa inhibitors. J Am Coll Cardiol 41 (5). 718-24. (Pubitemid 36308375)
21. Sorensen CR, Brendorp B., Rask-Madsen C., Kober L., Kjoller E. and Torp-Pedersen C. (2002) The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 23 (12). 948-52. (Pubitemid 35203873)
22. Bretzel RG (1997) Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy. Am J Hypertens 10 (9 Pt 2). 208S - 17S.
23. Adler AI, Stevens RJ, Manley SE, Bilous RW and Cull CA, Holman RR (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63 (1). 225-32. (Pubitemid 35463925)
24. Schnell O., Schafer O., Kleybrink S., Doering W. and Standl E., Otter W. (2004) Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. Diabetes Care 27 (2). 455-60. (Pubitemid 38174071)
25. Malmberg K., Norhammar A., Wedel H. and Ryden L. (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99 (20). 2626-32. (Pubitemid 29237448)
26. Braunwald E., Antman EM, Beasley JW, et al. (2000) ACC/ AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36 (3). 970-1.
27. Braunwald E., Antman EM, Beasley JW, et al. (2002) ACC/ AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (7). 1366-74.
28. World Health Organization (1999) 1999 World Health Organization- International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 17 (2). 151-83.
29. Miettinen H., Lehto S., Salomaa V., et al. (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21 (1). 69-75. (Pubitemid 28030388)
30. Otter W., Winter M., Doering W., Standl E. and Schnell O. (2007) C-reactive protein in diabetic and nondiabetic patients with acute myocardial infarction. Diabetes Care 30 (12). 3080-2. (Pubitemid 350255250)
31. Das UN (2002) Is insulin an endogenous cardioprotector ? Crit Care 6 (5). 389-93.
32. Schnell O. Sympathetic Innervation and Blood Flow in the Diabetic Heart. Kluwer Academic / Plenum Publishers, 2002.
33. Dibra A., Mehilli J., Schwaiger M., et al. (2003) Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. Eur Heart J 24 (12). 1128-33.
34. Lim SY, Jeong MH and Bae EH, et al. (2005) Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention. Circ J 69 (2). 154-8. (Pubitemid 40313033)
35. Matts JP, Karnegis JN, Campos CT, Fitch LL, Johnson JW and Buchwald H. (1993) Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group. J Fam Pract 36 (5). 497-503. (Pubitemid 23157105)